No New Trial for the 3rd Xarelto Bellwether Plaintiff
No New Trial for the 3rd Xarelto Bellwether Plaintiff

Introduction
The plaintiff of the 3rd Xarelto bellwether trial, which went in favor of the Xarelto defendants J&J's Janssen Pharmaceuticals and Bayer in August 2017, faced a defeat again when a Louisiana federal judge turned down the request for a new trial.
The plaintiff had planned for a retrial based on the recent scientific study that she hoped could change the jury's mind. Judge Eldon E. Fallon denied her request stating that the newly discovered evidence was actually cumulative of the previously known and admitted evidence.
Xarelto lawsuits are consolidated under MDL No.- 2592 in the U.S. District Court for the Eastern District of Louisiana; nearly 22,000 cases are a part of this MDL while more than 1,500 cases are pending in Philadelphia's Complex Litigation Center.
Latest News
First Federal Bellwether Trial Set in Strattice Mesh Case
Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…
Tepezza Hearing Loss Trial Set for June 2026
The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.
This decision comes as attorneys…